Pharmaceutical manufacturers face the daunting task of keeping up with serialization and track and trace regulations around the globe. Today, in nearly every major market across the world, governments are implementing regulations that will affect pharmaceutical supply chain operations and product marketability. Largely born out of the need to protect consumers, serialization and track and trace efforts provide not only consumer protections against counterfeit and contaminated drugs, but also provide manufacturers with the opportunity to lower costs by sharpening supply chain operations.
While there are commonalities among pharmaceutical supply chain operations, rfxcel understands that supply chain is a competitive asset and differentiator for our customers including unique business processes and country-specific regulations. This is why rfxcel never sells a one-size-fits-all solution. Our software suite is extensible to your specific needs, allowing a level of flexibility not provided by our competitors, while still delivering regular, non-disruptive software upgrades.
Whether you are a global or a niche manufacturer, our serialization product suite delivers the highest performance trace and trace supply chains anywhere around the world.